Listen to HER2

If you’ve been diagnosed with HER2-positive breast cancer, you know how the unique qualities of the disease impact your treatment, side effects and daily life. At Living Beyond Breast Cancer, we know that, too.

About 20 percent of breast cancers are HER2-positive, meaning they grow because of the human epidermal growth factor receptor 2 (HER2) protein. When there are too many HER2 proteins, breast cells grow faster than normal and can lead to breast cancer.

Though that 20 percent means about 50,000 new cases of HER2-positive breast cancer are diagnosed in the U.S. each year, many people have never heard of it. We want to change that.

That’s where Listen to HER2 comes in. All day on August 9, 2017, LBBC featured people who have been affected by early-stage or metastatic HER2-positive breast cancer on our blog. This diverse group of writers shared how HER2-positive breast cancer has affected their lives, their bodies, their emotions, their families, their finances, and more.

We hope you will learn something from our Listen to HER2 writers, and that, if you have HER2-positive breast cancer, you will see yourself reflected in some of their experiences.


Listen to HER2 is sponsored by



Susie Brain | AUGUST 9, 2017
For Listen to HER2, Susie Brain writes about having been diagnosed with HER2-positive breast cancer before trastuzumab was widely available. 
Read More

Rebecca Rioux | AUGUST 9, 2017
For Listen to HER2, Rebecca Rioux writes about the uncertainty that comes along with a "HER2-equivocal" diagnosis.
Read More

Monique Bryan | AUGUST 9, 2017
For Listen to HER2, on her blog, “Surprise! It's Cancer,” Monique Bryan writes about how her diagnosis affected her life as a newlywed looking forward to starting a family.
Read More

Erica Griffiths | AUGUST 9, 2017
For Listen to HER2, Erica Griffiths writes about having to stop breastfeeding after being diagnosed with metastatic breast cancer.
Read More

Katie Benson | AUGUST 9, 2017
Katie Benson was diagnosed with a large HER2-positive ductal carcinoma in situ, or DCIS, in 2013. For Listen to HER2, Katie answers questions about conflicted feelings she has about having been treated with surgery alone, and about her place in the breast cancer community.
Read More

Trevor A. Jolly, MBBS | AUGUST 9, 2017
For LBBC's Listen to HER2 program, Trevor A. Jolly, MBBS,  tells us why trastuzumab is so important, what we know about who is, and isn’t, getting treatment with it, and what can be done about it.
Read More

Erin Rowley  | AUGUST 9, 2017
For Listen to HER2, Kimberly Wooten answers questions about participating in a clinical trial of a HER2-targeted therapy.

Read More

Lianne Zhang  | AUGUST 9, 2017
In her Listen to HER2 post, on her blog, “The Pink Ribbon Effect,” Lianne Zhang says, “We can choose to rise from the ashes or become the ashes and for me – I’ll always choose to rise.”

Read More

Jamie Philippe | AUGUST 9, 2017
For Listen to HER2, Jamie Philippe writes about the financial difficulties she’s experienced because of breast cancer.

Read More

Christine Corrigan | AUGUST 9, 2017
Christine Corrigan wrote this piece in March 2017, 1 year after her diagnosis. She has graciously agreed for it to be used as part of Living Beyond Breast Cancer’s Listen to HER2 program.

Read More

Jessica Leip | AUGUST 9, 2017
For Listen to HER2, Jessica Leip writes about her diagnosis, HER2-targeted therapies and advocating for yourself.

Read More

Scott Leip | AUGUST 9, 2017
For Listen to HER2, Scott Leip writes about being a caregiver and about learning that listening is often the best form of help.

Read More

New In Listen to HER2 Carnival